블로그

IVIG

What To Do When IVIG Doesn’t Work

Doctor consults with patient about what to do when IVIG doesn't work

Worried about what to do when intravenous immune globulin (IVIG) doesn’t work or fails to work as expected? Take a breath. You have several treatment options with comparable or even better outcomes. 

Highlights

  • When IVIG doesn’t work, your provider may recommend alternative treatments, such as plasmapheresis, corticosteroids, and immunosuppressive agents. 
  • The choice of an alternative treatment is highly individualized.
  • Alternative treatments depend on co-existing medical conditions, age, potential risks, and availability/cost.

IVIG is an effective treatment for numerous autoimmune, inflammatory, and infectious conditions. But, like all medications, not everyone responds to IVIG equally, and some may not respond at all. 

Several factors may determine the success or failure of IVIG 치료, such as:

  • Individual patient factors
  • 나이 
  • Adherence to treatment plan 

Likewise, studies show that the percentage of responders can vary depending on the condition being treated. In this article, we discuss the alternatives to IVIG specific for various medical conditions. 

Also Read: How To Tell if IVIG Is Working

IVIG Alternatives in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Though IVIG is a first-line treatment for CIDP, about 1 in 4 people with CIDP don’t respond to it. When IVIG doesn’t work, your provider may prescribe immunosuppressive agents or monoclonal antibodies (mAbs) [1]. Additionally, some experts recommend switching from IVIG to 시그 (subcutaneous immunoglobulin).  

Immunosuppressive agents work by preventing the immune system from attacking the protective covering around nerve cells. Examples of immunosuppressives include azathioprine, mycophenolate mofetil, methotrexate, cyclosporine, and 사이클로포스파마이드

Rituximab, a monoclonal antibody, improves CIDP symptoms in treatment-resistant cases according to a 2022 review [2].

IVIG Alternatives in Guillain Barre Syndrome (GBS)

IVIG is the primary treatment for GBS. Yet, about 25% of people who don’t respond to it need mechanical ventilation, and 20% of people cannot walk without support after 6 months [3].

When IVIG doesn’t work, your provider may switch you to 혈장교환술 (plasma exchange) [4]. Plasmapheresis helps by removing the antibodies that attack your nerves. 

IVIG Alternatives in Kawasaki Disease (KD)

Though universal treatment guidelines are not available for KD, alternative treatments for IVIG-resistant KD include [4]:

  • A corticosteroid called methylprednisolone
  • A monoclonal antibody called infliximab (often considered the drug of choice)

IVIG Alternatives in Bleeding Disorders

If you have a bleeding disorder called immune thrombocytopenia (ITP), you are at risk of blood loss, especially during surgery. IVIG is commonly used before surgery to reduce the risk. 

A 2020 trial shows that an oral drug—eltrombopag—can be as effective as IVIG in people with ITP [5].

Consult an IVIG Specialist | The Best IVIG Home Infusion

(877) 778-0318

 

IVIG Alternatives in Immune Deficiency

Emerging evidence suggests that SCIG (subcutaneous immunoglobulin) may be a better option for people with immune deficiency. 
Unlike IVIG, SCIG results in the slow release of antibodies from the subcutaneous tissues into the blood. This allows antibody levels in the blood to remain steady. However, with IVIG, the antibody levels in the blood are more erratic.
Moreover, SCIG is more convenient because you can inject your dose at home or anywhere else at any time of day after some training. Additionally, side effects are less common with SCIG compared to IVIG. 
 

What Can Be Used Instead of IVIG?

In general, SCIG causes fewer side effects than IVIG. You may choose SCIG over IVIG if you:

  • Cannot tolerate IVIG side effects
  • Have poor venous access
  • Find SCIG more compatible with your lifestyle

Further Reading: SCIG vs. IVIG: Which Treatment Is Best for You?

참고문헌:

  1. Yoon, Min-Suk et al. “Standard and escalating treatment of chronic inflammatory demyelinating polyradiculoneuropathy.” Therapeutic advances in neurological disorders vol. 4,3 (2011): 193-200. doi:10.1177/1756285611405564
  2. Hu, Jianian et al. “Efficacy of rituximab treatment in chronic inflammatory demyelinating polyradiculoneuropathy: a systematic review and meta-analysis.” Journal of neurology vol. 269,3 (2022): 1250-1263. doi:10.1007/s00415-021-10646-y
  3. van Doorn, Pieter A et al. “IVIG treatment and prognosis in Guillain-Barré syndrome.” Journal of clinical immunology vol. 30 Suppl 1,Suppl 1 (2010): S74-8. doi:10.1007/s10875-010-9407-4
  4. Hao Q, Grobelna A; Authors. Alternative Therapies to Immunoglobulin for Guillain-Barré Syndrome: CADTH Health Technology Review [Internet]. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2023 May. Available from: https://www.ncbi.nlm.nih.gov/books/NBK594395/# 
  5. Arnold, Donald M et al. “Perioperative oral eltrombopag versus intravenous immunoglobulin in patients with immune thrombocytopenia: a non-inferiority, multicentre, randomised trial.” The Lancet. Haematology vol. 7,9 (2020): e640-e648. doi:10.1016/S2352-3026(20)30227-1
이 정보는 의학적 조언이나 치료를 대체할 수 없습니다. 새로운 치료를 시작하기 전에 담당 의사 또는 의료 서비스 제공자와 건강 상태에 대해 상담하십시오. AmeriPharma® Specialty Care는 제공된 정보 또는 그 결과로 내려진 진단이나 치료에 대해 어떠한 책임도 지지 않으며, 콘텐츠의 신뢰성에 대해서도 책임을 지지 않습니다. AmeriPharma® Specialty Care는 여기에 나열된 모든 웹사이트/기관을 운영하는 것은 아니며, 해당 콘텐츠의 가용성이나 신뢰성에 대해서도 책임을 지지 않습니다. 이러한 목록은 AmeriPharma® Specialty Care의 보증, 후원 또는 추천을 암시하거나 구성하지 않습니다. 이 웹페이지에는 AmeriPharma® Specialty Care와 제휴하지 않은 제약 회사의 상표 또는 등록 상표인 브랜드 처방약에 대한 참조가 포함될 수 있습니다.
의학적으로 검토됨 로버트 하킴 박사, 약학박사

로버트 채드 하킴 박사(약학박사)는 캘리포니아주 노스리지에서 태어나고 자랐습니다. 그는 위스콘신-매디슨 대학교 약학대학에서 약학 학위를 받았습니다. 그의 업무에서 가장 보람 있는 부분은 환자 치료에 미치는 영향을 극대화하는 임상 프로그램을 발전시키는 데 앞장서는 것입니다. 그는 중환자 치료 전문 자격증(BCCCP)을 보유하고 있으며, 중환자 치료, 약물 정보, 일반 의학, 심장학 분야의 전문 분야를 다룹니다. 여가 시간에는 여행을 즐깁니다. 

문의하기

아래 HIPAA 규격 양식을 사용하여 처방전 재조제를 요청하세요. 복용 중인 약이나 복용 방법에 대한 문의 사항이 있으시면 문의하기 페이지를 방문하시거나 다음 번호로 전화해 주세요. (877) 778-0318.

HIPAA Compliant

제출하면 AmeriPharma에 동의하는 것입니다. 이용 약관, 개인정보 보호정책, 그리고 개인정보 보호 관행 고지

ko_KRKorean